Table 1.
Participant characteristics
Variables | Boys | Girls |
---|---|---|
n | 32 | 47 |
Age | 12.54 (0.95) | 11.52 (0.83) |
BMI | 20.90 (3.15) | 20.33 (3.80) |
Tanner stage 1–2 (%) | 43 | 41 |
Tanner stage 3–5 (%) | 57 | 59 |
PDS – totala | 2.77 (1.05) | 3.07 (0.99) |
PDS – adrenal axisa | 2.66 (1.21) | 2.99 (1.07) |
PDS – gonadal axisa | 2.88 (1.24) | 3.17 (1.13) |
Composite z-score adrenal axis | 2.73 (1.02) | 2.89 (0.95) |
Composite z-score gonadal axis | 2.81 (0.81) | 3.09 (0.95) |
Composite z-score total | 2.77 (0.82) | 2.99 (0.89) |
DHEAraw | 119.32 (21.82) | 172.93 (15.18) |
DHEAlogb | 5.49 (0.59) | 5.85 (0.64) |
Testosteroneraw | 100.86 (15.47) | 55.63 (3.71) |
Testosteronelogb | 5.12 (0.57) | 4.71 (0.44) |
Estradiolraw | n/a | 1.56 (0.09) |
Estradiollogb | n/a | 1.02 (0.16) |
Note: Table values represent means, with standard deviations in parentheses, unless otherwise reported. DHEA: Dehydroepiandrosterone. BMI: Body Mass Index (n=30 boys and n=47 girls); Tanner staging data was available for 74 participants. DHEA and testosterone: n=30 boys and n=46 girls; estradiol: n=45 girls.
Ranging from 1 (development has not yet begun) to 5 (development seems complete).
Empirical Bayesian estimation scores that have been log transformed